Skip to main content

Journal of Gastrointestinal Cancer

Ausgabe 3/2022

Inhalt (40 Artikel)

Original Research

The Clinico-histopathological Spectrum of Tumors and Tumor-Like Lesions in Adult Intussusception

Pavithra Ayyanar, Gayatri Behera, Tushar Subhadarshan Mishra, Suvendu Purkait, Susama Patra, Suvradeep Mitra

Original Research

Short-term Outcomes of Gastric Cancer at University Teaching Hospital of Kigali (CHUK), Rwanda

Irénée Niyongombwa, Irénée David Karenzi, Isaie Sibomana, Vital Muvunyi, Jean Marie Vianney Kagimbangabo, Jean Christian Urimubabo, Antoine Nifasha, Egide Abahuje

Original Research

A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index

Giulia Rovesti, Francesco Leone, Giovanni Brandi, Silvia Cesario, Mario Scartozzi, Monica Niger, Changhoon Yoo, Roberto Filippi, Mariaelena Casagrande, Nicola Silvestris, Daniele Santini, Luca Faloppi, Andrea Palloni, Massimo Aglietta, Laura Bernardini, Hyungwoo Cho, Eleonora Lai, Elisabetta Fenocchio, Chiara Pircher, Donatella Iacono, Stefania De Lorenzo, Elisa Sperti, Valentina Massa, Filippo De Braud, Jae Ho Jeong, Giuseppe Aprile, Valentina Burgio, Stefano Cascinu, Andrea Casadei-Gardini

Original Research

Outcome Following Percutaneous Transhepatic Biliary Drainage (PTBD) in Carcinoma Gallbladder: a Prospective Observational Study

Vanji Nathan Subramani, Mohanasundaram Avudaiappan, Thakur Deen Yadav, Hemanth Kumar, Vishal Sharma, Harshal Mandavdhare, Ujjwal Gorsi, Harjeet Singh

Original Research

The Use of Single-Agent Versus Multiple-Agent Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer

Thomas Peponis, Caitlin Stafford, James Cusack, Christy Cauley, Robert Goldstone, David Berger, Aparna Parikh, Liliana Bordeianou, Hiroko Kunitake, Todd Francone, Rocco Ricciardi

Original Research

Laparoscopic Partial Gastrectomy for Large Gastric GISTs

Amr Abouzid, Ahmed Setit, Adel Fathi, Mosab Shetiwy

Original Research

Choosing the Appropriate Individualized Adjuvant Chemotherapy in Stage III Colon Cancer Patients Under and Over 70 Years

Heba F. Taha, Ola A. Harb, Loay M. Gertallah, Lobna A. Abdelaziz

Original Research

Combination Therapy with KRAS and P38α siRNA Suppresses Colorectal Cancer Growth and Development in SW480 Cell Line

Shiva Kamran, Ensiyeh Seyedrezazadeh, Dariush Shanehbandi, Milad Asadi, Venus Zafari, Najibeh Shekari, Leila Namvar, Habib Zarredar

Original Research

Procalcitonin and C-Reactive Protein as an Early Predictor of Infection in Elective Gastrointestinal Cancer Surgery—a Prospective Observational Study

Ujjwal Das, Amaranathan Anandhi, Sathasivam Sureshkumar, Apurba Shankar Sastry, Lakshminarayanan Subitha

Zur Zeit gratis COVID-19 Original Research

Identifying the Risk Factors for Mortality in Patients with Cancer and COVID-19 in Hamadan, the West of Iran

Malihe Safari, Javad Faradmal, Saeid Bashirian, Ali Reza Soltanian, Salman Khazaei, Ghodratollah Roshanaei

Original Research

Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia

Andri Sanityoso Sulaiman, Rino Alvani Gani, Irsan Hasan, Cosmas Rinaldi A. Lesmana, Juferdy Kurniawan, Chyntia Olivia Maurine Jasirwan, Kemal Fariz Kalista, Saut Horas Hotaguan Nababan, Gita Aprilicia, Laurentius A. Lesmana

Original Research

Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data

Hamed Manoochehri, Akram Jalali, Hamid Tanzadehpanah, Amir Taherkhani, Massoud Saidijam

Original Research

Extra-Colonic Malignancy in Inflammatory Bowel Disease: a Paucity of Recommendations with Weak Evidence

Simcha Weissman, Muhammad Aziz, Matthew R. Baniqued, Mohamed Ahmed, Sameh Elias, Joseph D. Feuerstein, James H. Tabibian

Original Research

Association of PARK-2 Non-synonyms Polymorphisms and Their In Silico Validation Among North Indian Colorectal Cancer Patients

Zafar Iqbal Bhat, Afreen Naseem, Bhupender Kumar, Kalaiarasan Ponnusamy, Raj Ranjan Tiwari, G. D. Sharma, M. Moshahid Alam Rizvi

Original Research

Moderate Prognostic Value of lncRNA FOXD2-AS1 in Gastric Cancer with Helicobacter pylori Infection

Ali Rajabi, Sepideh Bastani, Melika Maydanchi, Samaneh Tayefeh-Gholami, Sepehr Abdolahi, Ali Saber, Reza Safaralizadeh

Original Research

Pancreaticoduodenectomy: Impact of Volume on Outcomes at a Tertiary Care Center—Our Experience in Single Institute of Nepal

Sunit Agrawal, Bhawani Khanal, Ujjwal Das, Suresh Prasad Sah, Rakesh Kumar Gupta

Open Access Original Research

Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review

Robin R. Rodriguez, Stephen Abel, Jyothika Mamadgi, Paul B. Renz, Rodney E. Wegner, Moses S. Raj

Original Research

Utilization of Mutational Analysis (MA) in Gastrointestinal Stromal Tumor (GIST) Management in British Columbia (BC) Between January 2008 to December 2017: a Retrospective Population-Based Study

Tiffany Patterson, Jocelyn Chai, Haocheng Li, Angeline de bruyns, Chantell Cleversey, Cheng-Han Lee, Steven Yip, Christine Simmons, Jason Hart, Phil Pollock, Caroline Holloway, Pauline Truong, Xiaolan Feng

Original Research

Hypermethylation of MIR129-2 Regulates SOX4 Transcription and Associates with Metastasis in Patients with Colorectal Cancer

Alireza Rezayi Soufiani, Roya Dolatkhah, Mortaza Raeisi, Hadi Chavoshi, Payam Mohammadi, Abdolreza Mehdinavaz Aghdam

Original Research

Epidemiologic and Pathologic Study of Pancreatic Cancer in Hamadan, Iran (2008 to 2018)

Elham Khanlarzadeh, Saman Nazari, Mehdi Ghobakhlou, Hossein Ranjbar, Sasan Nazari

Zur Zeit gratis COVID-19 Review Article

Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review

Afrooz Mazidimoradi, Azita Tiznobaik, Hamid Salehiniya

Review Article

The Activity and Polymorphism of the PON1 in Patients with Chronic Liver Disease: a Systematic Review and Meta-analysis

Nader Salari, Mohsen Kazeminia, Kamran Mansouri, Amin Hosseinian-Far, Masoud Mohammadi

Review Article

The Role of Tumor Necrosis Factor-α (TNF-α) Polymorphisms in Gastric Cancer: a Meta-Analysis

Maryam Gholamalizadeh, Samaneh Mirzaei Dahka, Hadi Sedigh Ebrahim-Saraie, Mohammad Esmail Akbari, Azam Pourtaheri, Samira Rastgoo, Azadeh Hajipour, Afshin Shafaghi, Saied Doaei, Naser Kalantari

Review Article

Mitochondrial DNA Copy Number Variations in Gastrointestinal Tract Cancers: Potential Players

Mehdi Alikhani , Eliette Touati, Morteza Karimipoor, Massoud Vosough, Marjan Mohammadi

Case Report

Right-Sided Colonic Duplication Cyst with a Malignant Twist in a Young Adult — a Case Report

Laxmi Radhakrishnan, Joseph George, Latha K. Abraham

Case Report

A Case of Colonic Micropapillary Carcinoma with a High Frequency of Apoptosis

Kazumori Arai, Tomohiro Iwasaki, Hisato Ishimatsu, Chinatsu Tsuchiya, Aki Kubota, Akihiro Sonoda, Ko Ohata

Case Report

Anorectal Melanoma—Brownish Black Mass Not Always a Hemorrhoid

Jitendra Singh Nigam, Nishit, Tarun Kumar, Avinash Singh, Prerna Tewari, Jagjit Kumar Pandey

Case Report

Primary ALK-Positive Large B Cell Lymphoma of Pancreas

Pritika Kushwaha, Meeta Singh, Anubhav Vindal, Nidhi Verma, Shyama Jain

Case Report

A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?

Tuba Uğur, Fatih Gürler, Bülent Cengiz, Reha Kuruoğlu, Ahmet Özet

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.